Dimenhydrinate during pregnancy and lactation

Dimenhydrinate during pregnancy and lactation, Dimenhydrinate category by FDA, its use during pregnancy and lactation its teratogenic effects are described.

Small amount of drug excrete into breast milk, if required low dose should be prescribed.

Dimenhydrinate  during pregnancy and lactation
Pregnancy	Category  B      ( by FDA ) Category  A      (AU TGA)
	Dimenhydrinate drug crosses the placenta, Animal studies revealed no evidence of fetal harm, Clinical studies in pregnant women have not indicated an increased risk of abnormalities when this drug is administered in any trimester of pregnancy.
Breast feeding	Dimenhydrinate antihistamines are excreted into human milk in low concentrations, occasional doses are not expected to cause any adverse effects in breastfed infants.